On June 24, Oklo Inc. fell 5.13% in regular trading, trading at $55.01/share, with turnover of approximately $84.70 million.

Multiple negative catalysts continue to pressure the stock. Co-founder and CEO Jacob DeWitte along with Director Caroline Cochran sold approximately 339,000 Class A common shares through 10b5-1 plans at prices ranging from $64.99 to $70.45, eroding market confidence through concentrated insider selling at elevated levels. Additionally, UBS previously lowered its target price from $60 to $55 while maintaining a Neutral rating — with the current share price now breaching that target. Fundamentally, the company reported Q1 EPS of -$0.19 and a net loss attributable to the parent of $33.065 million, representing a 237.05% year-over-year deterioration, further intensifying valuation concerns for this pre-revenue advanced nuclear fission developer.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)